Zoledronate Therapy in Osteogenesis Imperfecta: Perspectives in Indonesia Tertiary Hospital
Zoledronate was safe and effective for the treatment of OI. There were significant improvements in the quality of life and BMD in patients with OI. The ALP level decreased, but serum creatinine and calcium levels were not affected by zoledronate.
Authors
- Tri Wahyu Martanto (ORCID: https://orcid.org/0000-0003-1273-8013)
- Rob G. H. H. Nelissen (ORCID: https://orcid.org/0000-0003-1228-4162)
- Aliefio Japamadisaw (ORCID: https://orcid.org/0009-0001-3021-7986)
- Dian Nurhayati
Institutions
- Universitas Airlangga (ID)
- Leiden University Medical Center (NL)
- Universitas Dr. Soetomo (ID)
Publication Details
- Journal
- Journal of Bone Metabolism
- Published
- 2024-11-05
- DOI
- https://doi.org/10.11005/jbm.24.767
- Primary Topic
- Connective tissue disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.00